Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Finished Drug Prices
NA
About the Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and chemical products, cat...
About the Company : NINGBO INNO PHARMCHEM CO.,LTD. develop, pilot and commercial produce organic chemicals, pharmaceutical intermediates and nutraceuticals. We also offer custom synthesis and manufact...
About the Company : Sincere to the customer and in good faith of quality is our forever followed motto. It’s the basement to be a human and do business. We take all responsibility for our products a...
Regulatory Info :
Registration Country : Ukraine
Brand Name : Apsorbin
Dosage Form : Powder for Oral Suspension
Dosage Strength :
Packaging : 3G Sachet
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Regulatory Info :
Registration Country : Vietnam
Brand Name : Smetstad
Dosage Form : Oral powder
Dosage Strength : 3G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Vietnam
Packaging :
Regulatory Info :
Dosage : Oral powder
Dosage Strength : 3G
Brand Name : Smetstad
Approval Date :
Application Number :
Registration Country : Vietnam
Global Sales Information
Main Therapeutic Indication : Others
Currency : USD
2015 Revenue in Millions : 133
2014 Revenue in Millions : 127
Growth (%) : -5%
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2016 Revenue in Millions : 118
2015 Revenue in Millions : 122
Growth (%) : -3
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2017 Revenue in Millions : 143
2016 Revenue in Millions : 138
Growth (%) : 4
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2018 Revenue in Millions : 143
2017 Revenue in Millions : 140
Growth (%) : 2%
Main Therapeutic Indication : Others
Currency : USD
2014 Revenue in Millions : 2.70%
2013 Revenue in Millions :
Growth (%) :
Market Place
Reply
25 Apr 2024
Reply
08 Feb 2021
Reply
04 Mar 2021
Reply
21 Aug 2019
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?